New funds in December: Charme, Aina II, Mediterrania, DCN, Mondragón

, , , ,
Integral service around a transaction
BY : Diego GutiérrezDecember Fri, 2017

Get to know the new venture capital funds and venture capital is that have emerged in the month of December and all the related information: size, commitments, objective, promoters,...

Find out about the new venture capital and venture capital funds that have emerged in the month of December and all related information: size, commitments, objective, promoters,...

Charme Capital Partners readies its new €650M European fund

The background Charme Capital Partners finalises the final closing of its new venture capital vehicle in Europe, which will arrive by the end of the year with an amount close to €650M. This amount far exceeds the initial target of €250m, with commitments of €400m.

The objective of this new fund is to invest in mid-sized European companies, with Spain, Italy and the UK as priority targets, with a valuation of €100M to €500M and strong growth potential. One of the investees of this new investment vehicle is Igenomix, a world leader in the development of genetic fertility tests. Its limited partners include family offices and industrial investors.


Aina Hospitality and Edmund de Rothschild launch Aina II

Aina Hospitalitya management company specialising in the hotel sector and promoted by the large asset management group Edmund de RothschildThe company plans to invest €600m with its second fund, which will target four-star superior and five-star hotels. The two entities have set up a joint venture to promote investment funds in the hotel sector every three years.

Fundraising will start in September and run for a year and a half, with a first closing window in March 2018. It aims to reach €300M and double its capacity to €600M with leverage. While in its first fund, Aina I, the minimum entry investment was €1M, for Aina II there is no set ticket, although it is expected to be higher. The return of Aina II will be close to 12% per annum and will extend its scope to 35 European cities, including countries outside the eurozone such as the UK, Switzerland and Scandinavia.


Mediterrania Capital Partners raises €103M for third African fund

The venture capital manager Mediterrania Capital Partners (MCP) is now ready to launch its third fund specialising in small and medium-sized companies in the Maghreb. Unlike the two previous vehicles, Mediterrania Capital III (MC III) will also invest in Egypt, Senegal, Cameroon and Côte d'Ivoire, in addition to Morocco, Tunisia and Algeria. The new fund already has €103m committed, slightly more than the €100m initially planned. Mediterrania expects to complete this vehicle by December 2018 with €250M. MC III will carry out eight to twelve transactions of €10M to €30M, in key sectors in North Africa and Sub-Saharan Africa, such as healthcare, consumer goods, finance, education, transport and logistics.

DCN registers its biomedicine fund Dosbio50 with the CNMV

The Valencian firm Decenes Mecenes (DCN) has registered with the CNMV the venture capital fund Dosbio50 Life Science & Health Care Venture Capital Investments, which plans to manage more than €40M to invest in seed and/or development capital projects in the biomedicine sector. Dosbio50 will be managed by its sole administrator, the DCN management company, which received in April the relevant authorization from the CNMV and is chaired by Lucas Martínez Clar and owned 5.49% by the Valencian investment firm Realiza Business Angels.

Throughout its ten years of existence, Realiza Business Angels has made a total of 17 investments in the Life Science sector (health sciences) with Artax Biopharma, Imegen, BioncoTech, Universal Diagnostics and the aforementioned Dosbio50; digital technology with Jugo, 50Tresdigital, Encom, Beroomers, Nextail and Weplan; as well as Soluble Film Packaking and Consultia Travel. It has also divested SFP, Corporate Channels, Geothermal Energy and Photomiracle.


Clave Mayor and Corporación Mondragón launch €15M fund for spin-outs

The Mondragon Corporation has launched "Mondragón Fondo de Promoción F.C.R.", already registered at the CNMV, operational and managed by the venture capital firm Major Key. This is a new investment vehicle for spin-outs that aims to support the technology transfer of innovative technology-based projects in the industrial, health and energy sectors, mainly from the Corporation itself.

The fund, closed with commitments of €15 million, also has the participation of FOND-ICO Global FCR, and the venture capital companies of the Basque and Navarre Governments, as well as the Provincial Council of Gipuzkoa. The investment vehicle will invest over the next 6 years in 30 companies with less than two years of life, remaining between 4 and 5 years in each of the investees and allocating up to €500,000 to each of them.


Genesis Ventures, a new biomedical investment fund, is born

Genesis Venturesa new investment fund based in Barcelona and made up of several family offices, will invest in very early-stage research and business projects in the biomedical field: therapeutics, diagnostics, medical devices, digital health, among others. Its objective is to help entrepreneurs to achieve the necessary value of their research in order to subsequently attract the first round of investment from corporate funds or venture capital (Series A). The new fund will have a size of around €610,000 and expects to do a total of eight deals by October 2019.

Eneko Knörr launches Pheidon, specialising in bitcoins

Eneko Knörr, supported by a team of blockchain and cryptocurrency experts from Silicon Valley, Singapore and Spain, has launched PheidonThe fund will start operating in 2018 and is still awaiting approval from the CNMV (Spanish Securities and Exchange Commission). The fund aims to facilitate investment in Bitcoin since, according to Knörr, "I have been seeing great interest in Spain in investing in Bitcoin for some time, but it is not easy: small savers find the process very complicated, and large fortunes do not have any funds from which to invest".

The M&A Professionals

Meet our services



Do you want to be up to date?


Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?